WESAIL debuts at CACLP to make POCT easier, faster and more accurate

Release time:

2023-04-28 14:07

The 18th China International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo ("CACLP") is underway in Chongqing, with more than a thousand related companies participating. As the flagship expo event of the in vitro diagnosis industry, CACLP attracts nearly 100,000 experts, scholars, entrepreneurs, manufacturers, distribution companies, investment banks, medical workers, etc. in related fields at home and abroad every year. It has become a weather vane for the development of the in vitro diagnosis industry. Guangdong Weishi Biotechnology Co., Ltd. (hereinafter referred to as "WESAIL") with the company's independent research and development of star products were invited to participate in the exhibition, attracting guests to stop frequently, especially the company's full range of new crown detection kits, but also won the extensive attention of the scene.

 

 

WESAIL's products include a series of diagnostic reagents and supporting instruments, with the advantages of "fast, accurate and convenient", focusing on infectious diseases, cardiovascular, inflammatory, tumor screening and reproductive fields. Among them, the full series of new coronavirus detection kits independently developed and produced by WESAIL were officially unveiled for the first time in China. The kit product has excellent performance and obvious advantages. It can be used for auxiliary diagnosis and screening at various stages such as the incubation period, infection period and vaccination period of the virus. The operation is simple, and the results can be quickly obtained in 6 to 15 minutes. The results can be interpreted by naked eyes without testing instruments, which greatly helps doctors to quickly diagnose and help prevent and control the epidemic.

 

 

In the face of the menacing new coronavirus epidemic, WESAIL, as an in vitro diagnostic enterprise, has actively assumed social responsibility and developed a series of new coronavirus detection products of different specifications, including new coronavirus (COVID-19) antigen detection kit, new coronavirus (COVID-19) antigen saliva detection kit, new coronavirus antigen influenza detection kit, new coronavirus (COVID-19) IgM/IgG detection kit and new coronavirus (COVID-19) neutralizing antibody detection kit. The superior product performance of WESAIL new crown series test kit has been officially recognized by many countries in the world, and has been exported to Germany, Italy, Russia, Romania, Brazil, Spain, South Korea, Japan and other countries, and has obtained official access permits from Germany, Russia, Turkey and France. At the same time, WESAIL is the layout of the new crown home testing kit, the WESAIL for the domestic market first, I believe that can also be recognized and appreciated by customers.

 

 

In the face of increasing medical demand, WESAIL adheres to the business development concept of "pursuing excellence, only truth and reality", attaches importance to product technology innovation and upgrading research and development, and is committed to providing diagnostic customers with excellent performance of immune reagent products and ingenious fluorescence analysis instruments. In the future, WESAIL will continue to take global customer needs as the starting point, actively carry out market development, ensure the sustainable development of products, provide patients with faster, more accurate and effective testing services, and contribute to the inclusive public medical environment.

 

 

CACLP continues, welcome to Chongqing International Expo CenterN4-S071Booth, WESAIL team awaits your arrival!

Recommended News